Fellowship Programs

IN GLOBAL MEDICAL AFFAIRS

BIOPHARMACEUTICAL INDUSTRY

Gain extensive experience

Medical Information Fellow

• Communication skills

• Critical thinking

• Project Management

• Medical Writing

• Scientific Expertise

• �Develop�accurate�and�scientifically�balanced written responses to unsolicited medical inquiries

• �Staff�Medical�Booths�at�Scientific�Congresses

• Develop strong project manage-ment and communication skills

• Support medical review and approval of promotional and educational materials

Medical Affairs Fellow

• Strategic thinking

• Problem solving

• Leadership

• Decision making

• Business acumen

• Learn how to develop a Global Medical Affairs Plan (MAP)

• Implement designated elements of�the�MAP�for�advisory�board�and�symposia�preparation

• Provide support in external engage-ment�with�key�stakeholders�(HCPs,�patients,�payers,�and�regulators)

• Support development of promotional,�non-promotional,�and�medical training materials

KEY SKILLS AND RESPONSIBILITIES

Dear Prospective Fellow,

I�am�delighted�by�your�interest�in�the�Alexion�fellowship�programs�in�collaboration�

with�Massachusetts�College�of�Pharmacy�and�Health�Sciences�(MCPHS)�University—

thank�you!�One�of�the�main�goals�of�these�fellowship�programs�is�to�increase�the�

visibility�of�the�contributions�that�the�Doctor�of�Pharmacy�profession�brings�to�the�

biopharmaceutical�industry.�Additionally,�the�programs�provide�the�fellow�the�

opportunity�to�gain�extensive�experience�within�Global�Medical�Affairs�including�

the�Global�Medical�Information�function.

Alexion�is�a�global�biopharmaceutical�company�focused�on�developing�and�

delivering�life-changing�therapies�for�patients�with�devastating�and�rare�diseases.�

Patients with these life-threatening diseases often have no effective treatment

options,�and�they�and�their�families�suffer�with�little�hope.�Our�goal�is�to�deliver�

medical�breakthroughs�where�none�currently�exist.�We�are�driven�because�we�know�

people’s�lives�depend�on�our�work.

As�we�pursue�our�mission,�the�Global�Medical�Affairs�team�including�Global�Medical�

Information�plays�a�critical�role�in�serving�these�patients�and�ensuring�the�safe�and�

proper�use�of�Alexion�products.

I�wish�you�the�best�of�luck�as�you�explore�the�opportunities�available�and�encourage�

you�to�consider�the�Alexion�fellowship�programs.

Sincerely,

Ulrich�Goldmann,�MD

Senior Vice President of Global Medical Affairs

and�Chief�Medical�Officer�

About Alexion 1992

YEAR FOUNDED

2,500 EMPLOYEES

50 COUNTRIES

20+ YEARS OF EXPERTISE IN COMPLEMENT BIOLOGY

Alexion (nasdaq:�alxn) is a global biopharmaceutical

company�focused�on�serving�patients�and�families�affected�

by�rare�diseases�through�the�discovery,�development�and�

commercialization�of�life-changing�therapies.Since�its�founding�in�1992,�Alexion�has�given�hope�to�

people who had none and shined a light on those who

felt�isolated�and�alone.�But�we�know�that�fighting�rare�

diseases�takes�so�much�more�than�hope.�It�requires�

persistence,�dedication,�and�a�relentless�pursuit�of�the�

highest�levels�of�medical�innovation.�At�Alexion,�our�

goal is to deliver medical breakthroughs where none

currently�exist.�We�are�driven�because�we�know�people’s�

lives�are�at�stake.

Alexion�has�2,500�passionate�and�dedicated�employees�

serving�patients�in�50�countries�around�the�world.

Through�the�transformative�power�of�our�science,�

Alexion has delivered life-changing therapies to

patients�suffering�from�rare�diseases.�We�have�

pioneered�the�complex�field�of�complement�biology�

and delivered solutions to challenges that once seemed

impossible for patients with devastating

complement-mediated�and�metabolic�disorders.

Alexion’s ambition is to be the global leader in rare

diseases.�By�leveraging�our�20+�years�of�expertise�in�

complement�biology�and�our�capabilities�in�hematology,�

nephrology,�neurology,�and�metabolic�disorders,�we�will�

bring additional life-changing therapies to patients and

redefine�what�it�means�to�live�with�a�rare�disease.�Our�

legacy�will�be�measured�in�the�families�we�serve�today�

and�the�generations�that�follow.

ALEXION�GLOBAL�HEADQUARTERS-BOSTONAlexion’s headquarters are located in Boston, Mass. in the heart of the Seaport District. New Haven serves as the Company’s Center of Excellence for its world-class complement research and process development teams. Both Alexion fellowship programs are based in Boston.

1992YEAR FOUNDED

2,500 EMPLOYEES

50 COUNTRIES

20+ YEARS OF EXPERTISE IN COMPLEMENT BIOLOGY

Patients�with�rare�diseases�are�our�guiding�star.� They�inspire�us�every�day�to�find�answers,�and�we�act� with�integrity,�urgency,�and�discipline�because�we�know�their�lives�are�at�stake.

Empower People

We trust, value, respect, and empower team members

We unlock value through diversity of people, ideas, cross-functional collaboration, and continuous learning

We celebrate success and embrace failure as an opportunity to learn and improve

Innovate for Solutions

We innovate with discipline and focus to seek creative solutions in all aspects of our work

We take balanced risks and encourage experimentation

We actively listen with humility to diverse internal and external inputs, and harness new ideas

Act�with�Integrity�

We embrace compliance and quality as essential to everything we do

We build trust and earn credibility by doing things the right way

We are all leaders and accountable to each other, patients, customers, stakeholders, and shareholders

Serve Patients

We put patients at the heart of decisions we make

We seek to understand patients’ journeys and with our passion and persistence, help each patient find answers and deliver transforma-tive therapies that change lives

We collaborate and partner with the world around us to create value for patients

Fellowship Programs

> GLOBAL MEDICAL INFORMATION

> GLOBAL MEDICAL AFFAIRS

Alexion/MCPHS�

These�two-year�fellowships�offer�an�opportunity�to�gain�extensive experience within global medical information and�global�medical�affairs�at�a�fast-paced,�exciting,� innovative,�patient-centric,�global�biopharmaceuti-cal�company�focused�on�developing�and�delivering�life-changing therapies for patients with devastating and�rare�diseases.

Through�the�Alexion�fellowship�program,�fellows�will� develop and strengthen core competencies that are key�to�a�successful�career�within�the�biopharmaceutical�industry.�These�competencies�include�strategic�and�analytical�thinking�as�well�as�project�planning�to�drive�results.�Attention�to�detail�and�the�ability�to�influence�others as well as strong communication and presenta-tion�skills�are�also�refined�throughout�a�two-year� fellowship�at�Alexion.�In�addition,�the�development�of�strong�business�acumen�in�combination�with�scientific�expertise�bolsters�the�fellow’s�versatility�and�ability�to�succeed�as�a�biopharmaceutical�professional.

Fellows will get exposure to cross-functional teams including�legal,�regulatory,�scientific�communications,�clinical�development,�field�medical,�pharmacovigilance,�medical/clinical�review,�marketing,�and�other�depart-ments.�Opportunities�to�attend�medical�congresses�may�

also�be�presented�during�each�fellowship.�Furthermore,�fellows�have�the�opportunity�to�expand�their� professional�network�through�interactions�with�highly�skilled�and�experienced�Alexion�employees.

Fellows will receive a competitive stipend and benefits�package,�including�comprehensive�health� and�dental�insurance.

MCPHS�and�Alexion�will�award�a�professional�certificate�upon�successful�completion�of�the�fellowship�program.

Alexion,�in�collaboration�with�MCPHS�University,�is�pleased�

to offer two unique postdoctoral fellowship programs to

expose�qualified�Doctor�of�Pharmacy�graduates�to�the�

biopharmaceutical�industry,�and�enhance�and�promote�

the�role�of�pharmacists�within�this�field.�Both�fellowships�

will�be�based�out�of�Alexion’s�headquarters�in�Boston.�

AS AN ADJUNCT INSTRUCTOR AT MCPHS, FELLOWS

WILL HAVE THE OPPORTUNITY TO:

•�Develop,�coordinate,�and�teach�courses

•��Co-precept�pharmacy�students�on�advanced� experiential rotations

•��Create�and�publish�scholarly�research�and/or� review articles

•�Present�research�at�scientific�and�clinical�meetings

• Participate in professional development seminars with�other�MCPHS�fellows

The medical information function within the biopharma-ceutical�industry�plays�a�significant�role�in�supporting�the�information�needs�of�healthcare�professionals,�patients,�caregivers,�and�third-party�payers.

Global Medical Information AT ALEXION

M edical information departments have access to the most accurate and up-to-date data on their�company’s�products�and�therapeutic�

areas�of�focus.�By�analyzing,�summarizing,�and�sharing�this�information�in�response�to�unsolicited�requests,�medical information facilitates the safe and effective use of medicines and informs healthcare decision- making,�which�has�a�positive�impact�on�patient�care.

Healthcare�professionals�who�become�medical� information providers within the biopharmaceutical industry�accrue�substantial�knowledge�and�skills�based�upon�their�professional�education,�clinical�and�scientific� training,�and�practice�experience.�In�addition�to�clinical�and�scientific�expertise,�a�successful�medical�informa-tion professional is able to understand and navigate intricate�regulatory,�legal,�and�corporate�issues�in�order�to�effectively�communicate�and�respond�to�complex�medical�information�requests.

Medical information departments provide customers with�accurate,�scientifically�balanced,�and�current�data�about disease states and related products and therefore are�typically�staffed�by�professionals�with�healthcare�or�scientific�degrees�and�relevant�scientific�training�and�backgrounds.�This�is�required�because�medical� information�professionals�need�to�thoroughly�under-stand�questions�posed�by�healthcare�professionals�(HCPs),�patients/caregivers,�and�third-party�payers� to ensure that the information provided is relevant; evidence-based�and�balanced;�accurate,�truthful,�and�non-misleading;�and�non-promotional�in�nature.

The Global Medical Information (GMI) department at Alexion�is�staffed�with�primarily�PharmDs�and�PhDs�with extensive experience within the biopharmaceutical industry�and�the�medical�information/communications�functional�area.�The�GMI�department,�along�with�

Scientific�Communications,�at�Alexion�fall�within�the�Medical Communications group which is part of the larger�Global�Medical�Affairs�organization.

The primary responsibility of the GMI department at Alexion is to provide responses to unsolicited requests for medical information that are scientific in nature; truth-ful, non misleading, accurate and balanced; tailored to answer the specific question(s) asked; and consistent with guidelines, best practices, and regulatory guidances. Additionally, the GMI group provides medical review and approval of promotional, educational and medical materials as part of the cross-functional medical, legal, regulatory review committees. Our GMI specialists meet this responsibility by:

• Developing extensive therapeutic area and product expertise

• Creating comprehensive standard response documents and custom responses to address questions being received around the globe

• Staffing medical booths at scientific congresses

• Collaborating with different field-based teams (including medical science liaisons (MSLs), sales representatives, and medical affairs managers)

• Preparing and delivering training materials regarding medical information processes

• Providing oversight of medical information contact center and ensuring tools, resources, and databases are available for documenting and handling unsolicited requests for medical information

• Serving as an integral part of cross-functional medical, legal, regulatory review committees by overseeing medical review and approval of promotional, educational and medical pieces in alignment with global medical directors

Global Medical Information Fellowship Team

Michael J. DeLuca, PharmD, MBA, MSRA DIRECTOR,�GLOBAL�MEDICAL�INFORMATION�&�MEDICAL�REVIEW� ALEXION�FELLOWSHIP�PROGRAM�DIRECTOR

Michael�joined�Alexion�in�May�2014�as�Director�of�Metabolic�Disorders�within�Global�Medical�

Information.�Before�joining�Alexion,�Michael�spent�six�years�at�Sunovion�Pharmaceuticals�

Inc.�in�various�roles�of�increasing�responsibility�and�most�recently�as�Director�of�Medical�

Information.�During�his�tenure�at�Sunovion,�he�managed�a�team�of�eight�PharmD’s�and�

Coordinators�supporting�the�respiratory�and�CNS�therapeutic�areas�through�multiple�

product�launches.�Prior�to�Sunovion,�Michael�worked�in�medical�publishing�and�led�the�

clinical�services�group�at�Physicians’�Desk�Reference�(PDR).�Additionally,�Michael�has�

had experience practicing as a retail pharmacist and spent a brief period of time in

pharmacovigilance�as�well.�Michael’s�educational�background�includes�a�Doctor�of�

Pharmacy�degree�from�the�University�of�Michigan,�an�MBA�in�Pharmaceutical�

Management�and�Operations�from�Seton�Hall�University,�and�a�Master�of�Science�

in�Regulatory�Affairs�degree�from�Northeastern�University.

Jonathan Wang, PharmD SENIOR�MANAGER,�GLOBAL�MEDICAL�INFORMATION�&�MEDICAL�REVIEW� ALEXION�FELLOWSHIP�PROGRAM�PRECEPTOR

Jonathan�arrives�from�Biogen�with�former�expertise�in�Scientific�Communications�

and�Global�Medical�Information.�Prior�industry�training�as�a�post-doctoral�fellow�at�

Biogen,�in�association�with�MCPHS�University,�allowed�him�to�develop�a�rigor�and�focus�

in�Global�Medical�Affairs.�Much�of�his�contributions,�to�date,�has�come�through�supportive�

efforts�in�medical�initiatives,�ranging�from�product�launch�planning,�medical�research,�

external�stakeholder�engagement,�and�data�generation.�He�brings�much�of�his�

medical�experience�supporting�assets�in�the�neurology,�immunology,�and�rare�disease�

space.�Jonathan�is�an�alumnus�of�the�University�of�Pittsburgh,�and�currently�resides�in�

the�greater�Boston-Cambridge�area.�In�his�free�time,�he�enjoys�photography,�traveling,�

and�eating�all�of�the�bountiful�fare�the�New�England�area�has�to�offer.

Vatché Demirjian, PharmD, RPh MANAGER,�MEDICAL�INFORMATION�&�MEDICAL�REVIEW�PROGRAM ALEXION�FELLOWSHIP�PRECEPTOR

Vatché�Demirjian�is�currently�a�Manager�of�Global�Medical�Information�and�Medical�Review�

supporting�Alexion’s�complement�franchise.�In�his�current�role,�Vatché�is�responsible�for�

serving�as�a�therapeutic�area�expert�for�atypical�Hemolytic�Uremic�Syndrome�(aHUS).�As�a�

manger,�Vatché�is�also�responsible�for�providing�support�to�US�field�teams,�global�affiliates,�

and�health�care�practitioners�internationally.�Prior�to�joining�Alexion,�Vatché�worked�as�an�

internal�medicine�pharmacist�at�Robert�Wood�Johnson�University�Hospital�(RWJUH)�in�

New�Jersey.�He�also�completed�a�PGY2�residency�specializing�in�Drug�Information�at�

RWJUH,�where�he�served�as�a�preceptor�to�APPE�and�IPPE�students.�Prior�to�his�residency,�

he�completed�a�post-doctoral�fellowship�in�medical�affairs�at�Haymarket�Medical�Education.�

Vatche�received�his�Doctor�of�Pharmacy�degree�from�MCPHS�University�in�Boston,�MA.�

Gabriela Marcheva, PharmD SECOND-YEAR�GLOBAL�MEDICAL�INFORMATION�FELLOW

Gabriela�joined�the�Alexion�Global�Medical�Information�team�in�July�2017.�Gabriela�is�

currently�in�her�second�year�of�the�fellowship�supporting�the�complement�franchise.�Prior�

to�joining�Alexion,�Gabriela�received�her�Doctor�of�Pharmacy�degree�from�Mercer�University�

College�of�Pharmacy�in�Atlanta,�GA.�Gabriela�completed�a�Medical�Information�rotation�at�

UCB�North-America�headquarters�in�Atlanta.�Additionally,�Gabriela�completed�a�number�of�

clinical�rotations�at�various�hospital�sites�in�the�Atlanta�region.�During�her�advanced�

practice�pharmacy�training,�Gabriela�gained�experience�in�a�variety�of�settings�including�

ambulatory�care,�managed�care,�and�retail�pharmacy.

Matthew Luen, PharmD FIRST-YEAR�GLOBAL�MEDICAL�INFORMATION�FELLOW

Matthew�joined�the�Alexion�Global�Medical�Information�team�in�July,�2018.�As�a�fellow�in�

the�Global�Medical�Information�team,�Matthew�supports�the�metabolic�disorder�franchises.�

Matthew�is�originally�from�Gaithersburg,�Maryland�and�received�his�Doctor�of�Pharmacy�

degree�from�Rutgers�University.�Prior�to�the�fellowship,�Matthew�completed�internship�

experiences�in�Medical�Information�at�Janssen�and�in�the�REMS�department�at�the�FDA.�

“ I AM TRULY EXCITED TO BE PART OF A BIOPHARMACEUTICAL COMPANY THAT SPECIALIZES IN THE TREATMENT OF RARE DISEASES. THE ALEXION GLOBAL MEDICAL INFORMATION FELLOWSHIP PROVIDES A UNIQUE OPPORTUNITY TO GAIN PRACTICAL AND VALUABLE HANDS ON EXPERIENCE THAT WILL ALLOW FOR A SUCCESSFUL AND FRUITFUL CAREER IN THE BIOPHARMACEUTICAL INDUSTRY.”

M A T T H E W L U E N �-�FIRST-YEAR�GLOBAL�MEDICAL�INFORMATION�FELLOW

The Alexion Global Medical Information Fellowship will give the fellow�the�opportunity�to�learn:• The core functions of global medical information:

- Respond to unsolicited requests for information

- Staff medical booths at medical congresses

- Perform literature searches

- Develop standard and custom responses

• Laws, regulations, regulatory guidances governing the medical information function

• Roles and functions of regulatory, legal, marketing, sales training, etc. by participating in cross-functional medical, legal, and regulatory review committees

• Drug development, particularly the development of biologics in the orphan drug/rare disease space

• Laws, regulations, and regulatory guidances governing marketing and promotion

• Roles and functions of different field-based teams (sales representatives, medical science liaisons, medical affairs managers, etc.)

The Alexion Global Medical Information Fellowship will provide�the�fellow�the�opportunity�to�further�develop�communications�skills�(both�verbal�and�written),�to�develop�project�management�skills,�to�increase�under-standing�of�drug�development,�and�to�learn�about�the�rare diseases and therapeutic areas in which Alexion is focused�on�developing�treatments.�These�areas�include:

HEMATOLOGY,�NEPHROLOGY,�NEUROLOGY,� AND�METABOLIC�DISORDERS.

During�the�first�year�of�this�fellowship,�the�fellow�will�focus on acclimating to the role and function of Global�Medical�Information,�and�learn�and�develop� an expertise about the diseases and therapeutic areas in�which�Alexion�is�focused.

The fellow will also begin to perform some of the core functions of global medical information which also includes�providing�medical�review�of�promotional,� educational and medical materials as part of the cross-functional�medical,�legal,�regulatory� review�committees.

During�the�second�year�of�the�fellowship,�the�fellow�will function as a core member of the Global Medical Information�team,have�the�opportunity�to�fully�experi-ence the role of a medical information specialist in the biopharmaceutical�industry�and�continue�to�assist�with�review�of�promotional�materials�as�part�of�the�Medical,�Legal,�and�Regulatory�review�team.�The�fellow�will�also�have�the�opportunity�to�take�an�elective�assignment�with another department based on business needs and�the�fellow’s�interests.�Possible�elective�assignments�could include a rotation at Alexion’s medical informa-tion�call�center,�regulatory�affairs�advertising�and� promotion,�scientific�communications,�a�ride�along�with�the�Medical�Science�Liaisons,�etc.�Furthermore,�the�fellow�will�have�the�opportunity�to�attend�professional�development�meetings�or�seminars,�such�as�the�Drug�Information�Association�(DIA)�Medical�and�Scientific�Communication�Annual�Forum.

Visit the research and development page at www.alexion.com to learn more about Alexion’s current pipeline.

Global Medical Information Fellowship

During my time at Alexion, I have gained invaluable experience in

the Global Medical Information function. Working at a company

dedicated to developing robust therapies in the space of rare diseases

is extremely exciting and rewarding. Due to the flexibility of the

fellowship program, I am also able to gain exposure to other depart-

ments such as Scientific Communications, Field Medical, Regulatory,

etc. This fellowship has provided me the opportunity to identify areas

of best interest and shape a well-rounded experience in order to

better prepare myself for a successful industry career.

G A B R I E L A M A R C H E V A �-�SECOND-YEAR�GLOBAL�MEDICAL�INFORMATION�FELLOW

“

“

Health�care�practitioners,�regulators,�payers�and�other� customers are demanding sophisticated clinical and health-outcomes�data�and�analyses�to�support�the� approval,�reimbursement,�and�prescription�of�new� medicines.�We�must�reorient�our�thinking�along�the�lines�of�value�delivered,�articulating�value�propositions�that�are� appropriate�and�relevant�to�the�right�customers,�and� proactively�impact�the�environment�from�early�stage� gates�and�throughout�the�product’s�lifecycle.

Global Medical Affairs AT ALEXION

T he�primary�responsibility�of�the�Global�Medical�Affairs team is to develop the Global Medical Affairs�strategic�plan,�namely�evidence�

generation�(phase�IIIB/IV�studies),�scientific�commu-

nications,�and�scientific�engagement.�Global�Medical�

Affairs�consists�of�a�variety�of�core�functions�including�

Medical�Communications,�Health�Outcomes�Research,�

Medical�Operations,�and�Field�Medical.�In�addition,�the�

Global�Medical�Affairs�team�works�closely�with�a�wide�

range�of�other�functional�areas�including�Commercial,�

Clinical�Development,�Regulatory,�Compliance,�and�

others.�This�collaboration�facilitates�the�achievement�

of Alexion’s goal of developing and delivering

life-changing therapies for patients with devastating

and�rare�diseases.

Global Medical Affairs Leaders (GMALs) lead groups of

Global Medical Directors who help develop and drive

the execution of the Global Medical Affairs strategic

plans.�Based�on�global�guidance,�country-level�medical�

affairs teams develop their local Medical Affairs Plans

that�are�in�line�with�country-specific�strategies,�laws,�

and�regulations.�The�Global�Medical�Affairs�fellow�will�

work�closely�with�Global�Medical�Directors�and,�later�

in�the�fellowship,�may�have�the�opportunity�to�obtain�

country-level�medical�affairs�experience.�Furthermore,�

the fellow will have the chance to work with other

medical affairs stakeholders and cross-functional

teams in order to obtain a complete medical affairs

experience and to develop core competencies critical

for�medical�affairs�professionals.

Anna Petryk, MD SENIOR�MEDICAL�DIRECTOR,�GLOBAL�MEDICAL�AFFAIRS�LEAD,�HPP ALEXION�FELLOWSHIP�PROGRAM�PRECEPTOR�

Anna�Petryk�is�a�Senior�Medical�Director�

and a Global Medical Affairs Lead for

HPP�at�Alexion�Pharmaceuticals.�Prior�

to�joining�Alexion,�Anna�was�a�tenured�Professor�of�Pediatrics�

at�the�University�of�Minnesota,�specializing�in�pediatric�endocri-

nology.�Anna�completed�her�medical�school�training�in�Poland�

and�Scotland,�followed�by�residency�training�in�pediatrics�at�

Miami�Children’s�Hospital�and�a�pediatric�endocrine�fellowship�

at�Duke�University.�She�was�voted�one�of�the�Best�Doctors�in�

America and has extensive experience mentoring graduate

students�and�postdoctoral�fellows.�She�has�served�on�steering�

committees�of�training�programs,�review�panels�for�external�

funding�agencies,�and�several�editorial�boards.�Anna�has�pub-

lished�92�papers,�authored�9�book�chapters,�and�presented�over�

160�abstracts�at�national�and�international�meetings.�She�was�

a leading contributor to published consensus statements and

guidelines�on�behalf�of�the�Pediatric�Endocrine�Society.�

Adam Quicquaro, PharmD FIRST-YEAR�GLOBAL�MEDICAL�AFFAIRS�FELLOW

Adam joined the Alexion Global Medical

Affairs�team�in�July,�2018.�As�a�fellow�in�

the�Global�Medical�Affairs�department,�

Adam supports the metabolic disorder

franchises.�Adam�is�originally�from�Watertown,�Connecticut�

and�received�his�Doctor�of�Pharmacy�degree�from�MCPHS�

University�in�Boston,�Massachusetts.�Prior�to�the�fellowship,�

Adam completed internship experiences in Global Medical and

Clinical�Review�at�Alexion�Pharmaceuticals�and�in�the�Global�

Medical�Affairs�department�at�BD�Medical.�

Global Medical Affairs Fellowship Team

Global Medical Affairs Fellowship

The Alexion Global Medical Affairs Fellowship will give the fellow the opportunity�to:• Learn how to develop a Global Medical Affairs Plan (MAP) and an integrated evidence/scientific communication plan under the direction of the Global Medical Affairs Leader (GMAL).

• Develop capabilities on how to implement designated elements of the MAP, such as preparation for advisory boards and symposia in full compliance with scientific engagement standards and regulations.

• Provide insightful medical/scientific input to brand campaigns and launches.

• Support the development of promotional, non- promotional, and training materials in accordance with codes/regulations.

• Support excellence in external engagement with key stakeholders (HCPs, patients, payers, and regulators) to gain a deep understanding of customer needs.

• Learn how to identify data gaps and design appropriate studies to support those data gaps in partnership with commercial and development colleagues, including:

- Supporting the Integrated Global Medical Affairs team

� -��Reviewing�Investigator�Sponsored�Research�(ISR)�proposals to assess their strategic value based on scientific�merit�and�strategic�need

- Developing Alexion-sponsored research

THE ALEXION GLOBAL MEDICAL AFFAIRS FELLOWSHIP WILL PROVIDE THE FELLOW THE OPPORTUNITY TO FURTHER DEVELOP CORE

MEDICAL COMPETENCIES, NAMELY:

1. Scientific and technical expertise;

2. Medical and value access;

3. Executional and operational excellence; and

4. Engagement skills (both verbal and written).

The Global Medical Affairs fellowship at Alexion offers a unique

opportunity for the fellow to work directly under highly experienced

senior leaders in the rare disease realm. Shortly into the fellowship,

the fellow will discover unmet medical needs for patients with rare

and life threatening diseases. As I operate in the Global Medical Affairs

department, I find fulfilling work that addresses these unmet medical

needs that confront rare disease patients each day. The program

simultaneously provides me with an invaluable experience that

will foster my development as I transition from a fellow into a

biopharmaceutical industry professional.”

A D A M Q U I C Q U A R O - FIRST-YEAR�GLOBAL�MEDICAL�AFFAIRS�FELLOW

“

“

MCPHS�University�provides�an�academic�environment�to�guide and support fellows toward a successful career in the biopharmaceutical�industry.�As�a�private�institution�with�a�history�of�specializing�in�health�sciences,�MCPHS�University�offers�programs�that�embody�scholarship,�professional� service,�and�community�outreach.

MCPHS�University

Through�MCPHS�University,�the�fellow�will�have�the�opportunity�to�gain�teaching�and�research�experience�in�an�academic�setting.�MCPHS�University�faculty�and�company�program�leaders�mentor�fellows�according�to�their�scholarly�and�professional�interests�throughout� the�two-year�program.

Amee Mistry, PharmD DIRECTOR�OF�THE�POSTDOCTORAL�BIOPHARMACEUTICAL�INDUSTRY�FELLOWSHIP�PROGRAM

Dr.�Amee�Mistry�is�an�Associate�Professor�of�Pharmacy�Practice�and�has�been�with�MCPHS�

University�since�2006.�Dr.�Mistry�earned�her�PharmD�at�the�Albany�College�of�Pharmacy�and�

completed�a�PGY1�Community�Practice�Residency�with�Walgreens�and�MCPHS�University.�

In�2015,�Dr.�Mistry�took�over�as�Director�of�the�MCPHS�Biopharmaceutical�Industry�Fellowship�

program.�She�works�directly�with�leaders�in�the�area�to�continue�to�foster�growth�and�develop-

ment�of�the�post�graduate�program,�and�to�assist�the�fellows�in�attaining�positions�within�the�

pharmaceutical�industry.�She�also�continues�to�teach�and�conduct�scholarly�work�at�MCPHS�

University,�trains�pharmacists�and�student�pharmacists�nationally�on�immunizations,�and�is�

actively�involved�in�her�state�and�national�pharmacy�organizations.

Sheila M. Seed, PharmD, MPH, RPh MCPHS�FACULTY�PRECEPTOR

Sheila�is�Professor�and�Interim�Chair�of�Pharmacy�Practice�at�MCPHS�University,�School�of�

Pharmacy�Worcester/Manchester.�She�has�been�with�the�University�since�2001�where�she�teaches�

several�courses�related�to�public/global�health,�has�an�ambulatory�care�practice�site�and�works�

collaboratively�with�an�infectious�disease�specialist�at�a�travel�clinic.�She�received�her�BS�in�

Pharmacy�from�the�Massachusetts�College�of�Pharmacy�and�Health�Sciences,�a�Master’s�in�

Public�Health�from�the�University�of�Massachusetts,�Amherst�and�a�Doctor�of�Pharmacy�from�

Idaho�State�University.�She�also�served�as�a�pharmacy�officer�in�the�U.S.�Air�Force.�She�is�a�

member�of�several�professional�societies,�including�the�International�Society�of�Travel�Medicine,�

where�she�serves�as�a�pharmacy�steering�committee�member;�the�American�Association�of�

Colleges�of�Pharmacy�where�she�has�served�on�a�number�of�committees�within�the�Public�

Health�SIG;�and�the�American�Pharmacists�Association,�where�she�was�a�Coordinator�of�the�

APhA�Immunizing�Pharmacists�SIG.

MCPHS University Team

Eligibility

The�MCPHS�Biopharmaceutical�Industry�fellows�will� be�selected�on�a�nationally�competitive�basis,�with� interviews�at�the�American�Society�of�Health�Systems�Pharmacists�(ASHP)�Midyear�meeting.�

•��Applicants�must�have�a�Doctor�of�Pharmacy�degree�from�an�ACPE�accredited�college�of�pharmacy�at�the�commencement�of�the�program.

• Candidates must have strong written and verbal communication skills and a strong interest in pursuing a�career�within�the�biopharmaceutical�industry.

• All candidates must have authorization to work in the United�States�throughout�the�duration�of�the�one�or�two�year�fellowship.�No�visa�sponsorship�will�be�provided.�

Application Procedure

BEFORE ASHP MIDYEAR CLINICAL MEETING

Registration�is�required�with�the�American�Society�of�Health-Systems�Pharmacist�(ASHP)�Midyear�Clinical�Meeting Personnel Placement Service (PPS) to interview�at�Midyear.�In�addition,�to�be�scheduled�for�an�interview�at�the�ASHP�Clinical�Midyear�Meeting,�appli-cants must upload the following application materials to�the�online�portal�(www.mcphs.fluidreview.com/)�by�November�26th,�2018:

• Letter of intent

• Curriculum vitae

•��Unofficial�college�transcript

• Contact information of three references for letters�of�recommendation.�

Application Process

AFTER ASHP MIDYEAR CLINICAL MEETING

Three letters of recommendation must be submitted by�the�three�references�provided�no�later�than� December�10,�2018.

ONSITE INTERVIEWS

Top candidates will be invited for onsite interviews at�the�sponsoring�company’s�location.�

Final candidates will be required to go through additional�screening�/�onboarding�as�required�by�MCPHS�University.�

For�more�information,�please�email:� PharmD.Fellowships@alexion.com

Alexion Pharmaceuticals, Inc.

121 Seaport Boulevard

Boston,�MA�02210

MCPHS University

BOSTON CAMPUS 179�Longwood�Avenue Boston,�MA�02115-5896

MANCHESTER CAMPUS 1260�Elm�Street Manchester,�NH�03101

WORCESTER CAMPUS 19 Foster Street Worcester,�MA�01608-1715